Scientific Advances and Improvements in Our Understanding the Pathoimmunobiology of Atopic Dermatitis: Focus on Novel Treat¬ment Targets, Cytokine Signaling Systems, Th2 immune Response, and the Role of Interleukin-Mediated Inflammation in AD - Rationale for Evaluating Biologic Agents and Target¬ing New Mechanisms-of-Action and Molecular Signatures in Patients with Moderate-to-Severe and/ or Resistant Atopic Dermatitis - Mette S. Deleuran, MD, DMSc

Scientific Advances and Improvements in Our Understanding the Pathoimmunobiology of Atopic Dermatitis: Focus on Novel Treat¬ment Targets, Cytokine Signaling Systems, Th2 immune Response, and the Role of Interleukin-Mediated Inflammation in AD - Rationale for Evaluating Biologic Agents and Target¬ing New Mechanisms-of-Action and Molecular Signatures in Patients with Moderate-to-Severe and/ or Resistant Atopic Dermatitis - Mette S. Deleuran, MD, DMSc

Published

October 30, 2015

Created by

CMEducation Resources symposium